Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 17, Number 23, 2011

Articles

Favourites:
ADD
Favourites:
ADD

Glioma Stem Cell Maintenance: The Role of the Microenvironment
pp. 2386-2401(16)
Authors: M. Heddleston, John; Hitomi, Masahiro; Venere, Monica; A. Flavahan, William; Yang, Kenneth; Kim, Youngmi; Minhas, Sana; N. Rich, Jeremy; B. Hjelmeland, Anita

Favourites:
ADD

The Role of Integrins in Glioma Biology and Anti-Glioma Therapies
pp. 2402-2410(9)
Authors: Tabatabai, Ghazaleh; Tonn, Jorg-Christian; Stupp, Roger; Weller, Michael

Favourites:
ADD

Targeting the AKT Pathway in Glioblastoma
pp. 2411-2420(10)
Authors: A. McDowell, Kelli; J. Riggins, Gregory; L. Gallia, Gary

Favourites:
ADD

Bioenergetics Pathways and Therapeutic Resistance in Gliomas: Emerging Role of Mitochondria
pp. 2421-2427(7)
Authors: E. Griguer, Corinne; R. Oliva, Claudia

Favourites:
ADD

Preclinical Development of Novel Anti-Glioma Drugs Targeting the Endoplasmic Reticulum Stress Response
pp. 2428-2438(11)
Authors: H. Schonthal, Axel; C. Chen, Thomas; M. Hofman, Florence; G. Louie, Stan; A. Petasis, Nicos

Favourites:
ADD

New Perspectives in Glioma Immunotherapy
pp. 2439-2467(29)
Authors: Daga, Antonio; Bottino, Cristina; Castriconi, Roberta; Gangemi, Rosaria; Ferrini, Silvano

Favourites:
ADD

Targeting ErbB Receptors in High-Grade Glioma
pp. 2468-2487(20)
Authors: Berezowska, Sabina; Schlegel, Jurgen

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content